Stalevo 200

See also: Generic Stalevo 100, Generic Stalevo 125, Generic Stalevo 150, Generic Stalevo 50, Generic Stalevo 75

Stalevo 200 is a brand name of carbidopa/entacapone/levodopa, approved by the FDA in the following formulation(s):

STALEVO 200 (carbidopa; entacapone; levodopa - tablet; oral)

• 
  Manufacturer: ORION
  
  Approval date: August 2, 2007
  
  Strength(s): 50MG;200MG;200MG ^[RLD]

Has a generic version of Stalevo 200 been approved?

No. There is currently no therapeutically equivalent version of Stalevo 200 available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Stalevo 200. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmacologically active catechol derivatives
  Patent 5,446,194
  Issued: August 29, 1995
  Inventor(s): Backstrom; Reijo J. & Heinola; Kalevi E. & Honkanen; Erkki J. & Kaakkola; Seppo K. & Kairisalo; Pekka J. & Linden; Inge-Britt Y. & Mannisto; Pekka I. & Nissinen; Erkki A. O. & Pohto; Pentti & Pippuri; Aino K. & Pystynen; Jarmo J.
  Assignee(s): Orion-yhtyma Oy
  A compound according to formula 1 ##STR1## wherein R.sub.1 and R.sub.2 independently represent hydrogen, carbamoyl which is substituted by an alkyl of 1 to 4 carbon atoms, alkylcarbonyl of 2 to 5 carbon atoms or phenyl carbonyl, X represents halogen nitro or cyano and R.sub.3 represents ##STR2## wherein R.sub.4 represents cyano or alkylcarbonyl of 2 to 5 carbon atoms and R.sub.5 represents carbamoyl which is unsubstituted or substituted with alkyl of 1 to 8 carbon atoms or which is substituted with hydroxyalkyl of 1 to 8 carbon atoms or pharmaceutically acceptable esters and salts thereof, and a pharmaceutically acceptable carrier therefor, as well as pharmaceutical compositions containing said compounds as COMT inhibitors.
  
  Patent expiration dates:
  
  
  • October 19, 2013
    
    ✓ 
    Drug substance
  
  



• 
  Pharmaceutical composition comprising entacapone, levodopa, and carbidopa
  Patent 6,500,867
  Issued: December 31, 2002
  Inventor(s): Matti; Virkki & Kari; Vahervuo & Marja; Ritala & Marja; Partanen & Mervi; Niskanen & Jarmo; Lintulaakso & Marja; Laaksonen & Lasse; Kervinen & Sari; Kallioinen
  Assignee(s): Orion Corporation
  An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
  
  Patent expiration dates:
  
  
  • June 29, 2020
    
    ✓ 
    Patent use: TREATMENT OF PARKINSON'S DISEASE
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical composition comprising entracapone, levodopa, and carbidopa
  Patent 6,797,732
  Issued: September 28, 2004
  Inventor(s): Matti; Virkki & Kari; Vahervuo & Marja; Ritala & Marja; Partanen & Mervi; Niskanen & Jarmo; Lintulaakso & Marja; Laaksonen & Lasse; Kervinen & Sari; Kallioinen
  Assignee(s): Orion Corporation
  An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
  
  Patent expiration dates:
  
  
  • June 29, 2020
    
    ✓ 
    Drug product
  
  

See also...

• Stalevo 200 Consumer Information (Cerner Multum)
• Carbidopa/Entacapone/Levodopa Consumer Information (Wolters Kluwer)
• Carbidopa/Levodopa/Entacapone Consumer Information (Wolters Kluwer)
• Carbidopa, entacapone, and levodopa Consumer Information (Cerner Multum)
• Carbidopa, entacapone, and levodopa Advanced Consumer Information (Micromedex)